His research strategy is based in large part on the analysis of signalling pathways in single living β-cells, through the marriage of modern molecular biology and state-of-the-art digital imaging. Thus, he has developed the use of microinjection combined with recombinant bioluminescent and fluorescent probes to enable him to manipulate the living ß-cell in a wide variety of ways and to explore the events which underlie the triggering of insulin release. He has also studied the regulation of β-cell genes, and in particular the role and regulation of pancreatic duodenum homeobox-1 (PDX-1), which give us important insights into the maintenance of the β-cell "phenotype".
Guy Rutter has served on the Biochemical Society Council and on NIH, JDRFI and other international grant awarding bodies. He is an Editor of the Biochemical Journal and sits on the Wellcome Trust's Physiological Sciences panel and the board of several biomedical journals.
2004 Castelli Pedroli Prize, 19 th Camillo Golgi Lecture Dr Antonio Ceriello Chair of Internal Medicine, University of Udine, Udine, Italy
Brief Report of Research
Over the last several years Prof Ceriello has performed a significant amount of original research on the relationship between oxidative stress, post-prandial hyperglycaemia and diabetic complications. It is remarkable that his work is interdisciplinary in nature, including both clinical investigation and studies in cell culture, and employing a wide range of clinical, biochemical and molecular techniques to address research questions in a comprehensive manner. This is particularly apparent in his continuing series of studies on the role of hyperglycaemia, particularly postprandial hyperglycaemia, and oxidative stress in altered vascular relaxation and thrombosis in diabetes and on the beneficial effects of controlling post-prandial hyperglycaemia and administrating various antioxidants to counteract these changes. His clinical research is complemented by recent work demonstrating that intermittent high glucose has a direct toxic effect on cultured human endothelial cells, providing a possible mechanism for post-prandial hyperglycaemia in favouring diabetic complications. He has also shown that hyperglycaemia induces the expression of oxidative stress response genes, and that this response is defective in diabetic patients developing nephropathy. These data are consistent with the recent evidence, published by Ceriello and co-workers, that post-prandial hyperglycaemia induces oxidative stress and antioxidant consumption in diabetic patients. These results not only implicate post-prandial hyperglycaemia and oxidative stress in the pathogenesis of diabetic complications, but suggest that the control of post-prandial hyperglycaemia as well as antioxidant therapy may be useful as a complement to current strategies for preventing the development of these complications. This has resulted in a narrowing of the 1 LOD support interval to 9.6 cM. Two SNP markers located close to D5S1359 show a LOD above 3 in single point analysis in the Swedish families. An association analysis using the PDT program revealed that 7 markers show evidence of association. An analysis of associated haplotypes formed by three markers revealed that three haplotypes were associated; C-C-G was positively associated (p<0.002) while G-G-A and C-G-G were negatively associated (p<0.002). These three markers map in to the same gene. We are in the process of typing these three markers in independent case-control material to confirm the association. Additional SNPs are also being identified and analysed in the Swedish families in and around the associated region (Manuscript, 2004) . I have also investigated the IL12 region on chromosome 5, which previously has been both linked and associated to T1DM. Three additional markers were analysed in this region but revealed no linkage or association (Ann N Y Acad.
1005: 352-55, 2003). R 81
A short summary of my research During the proposed fellowship, Dr. Hillier aims to determine how moderate weight change alters the pathophysiology of insulin resistance and other components of the metabolic syndrome in a population with a background of relatively low obesity. The primary study population will be a cohort of more than 5,000 French adults aged 30-64 without prior known diabetes, who have been followed prospectively for more than six years with extensive biologic measurements and ascertainment of lifestyle habits. Additionally, she will use the French national survey of adults treated for diabetes to assess whether clinical and economic outcomes are worse among adults with Type 2 diabetes who are overweight or obese, compared to normal weight adults with Type 2 diabetes.
These aims can be feasibly accomplished within one year, and will yield at least two manuscript submissions during this fellowship. Most importantly, Dr. Hillier will gain needed statistical and analytical skills, providing a springboard for unlimited unique future colloborations to alter the current course of our worldwide obesity epidemic.
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The project of Dr Hillier has two specific aims that uniquely combine the strengths of the colloborators and their readily available data in a novel epidemiologic evaluation of the impact of early obesity. This is a natural extension of Dr. Hillier's work over the last five years to evaluate outcomes of obesity in the U.S. population. Importantly, this fellowship among an internationally renowned team of diabetes epidemiologists gives Dr. Hillier the invaluable opportunity to gain additional diabetes epidemiology skills not available in her current research environment. The system includes methods to optimise contrast and to recognise normal structures, such as blood vessels and the optic disk. Candidate DR lesions are segmented out using region growing algorithms, one for dark lesions, such as haemorrhages and microaneurysms, and another for bright lesions, such as exudates. Artificial neural networks are used to classify candidate lesions as true DR or 'noise', the latter category including non-DR features such as drusen. At optimum settings, overall sensitivity for 'any retinopathy' was 94.8% with specificity 52.8% on a per patient basis. At these settings, no cases of sight-threatening retinopathy were missed by the system; 50.6% of images and 34.7% of patients could safely be removed from the graders workload.
A valid criticism of all published work to date, including our own, is that investigators have manually excluded ungradeable images before image processing. In view of this, a method to detect ungradeable images, utilizing the total area of visible blood vessels across the image is now being developed. Preliminary results correspond closely to the opinion of clinical graders.
Questions not adequately addressed as yet include evaluation of the reliability of this system on a larger set of images, and looking at the practicalities of implementing the system outside the image processing laboratory, within a clinical screening program. This award will enable us to begin to address these questions by installing the system on site for a pilot field study. This will utilize images from a community based DR screening program. We hope to analyse images from several thousand patients and to compare system results to those of trained graders and clinicians. At the same time we will begin to look at how the system could safely be brought into clinical use, and for what its true practical benefits and limitations might be. I look forward to reporting our findings in due course. Diabetic retinopathy (DR) remains the commonest cause of blindness in the working age population of the developed world. Visual loss can usually be prevented if DR is detected sufficiently early, and the need for comprehensive DR screening has long been recognized. With digital retinal photography such screening is now possible. In the UK, the National Screening Committee has recommended digital photography as the preferred method for DR screening, and the National Service Framework for Diabetes requires DR screening of all patients with diabetes by 2007.
The salaries of staff trained to review retinal photographs will be a major cost of such screening. Quality assurance is also a major concern. In the long term, automated image processing may be able to reduce the number of images requiring human grading, with associated cost reductions. In the shorter term it may have a role as a cost effective quality assurance method.
A large number of studies have reported preliminary results for varying approaches to automated DR detection. However . Originally, micro-satellite markers were mapped in 144 families of French origin (637 individuals) and analysed for linkage with a T2D phenotype in combination with or without glucose intolerance, a normal body weight or an early age of diabetic onset (<45 years at the diagnosis). This resulted in identification of the locus on chromosome 2p, for which a fine-mapping with 42 additional microsatellite markers was performed, and to which a positional cloning in combination with candidate gene approach was applied.
Besides the data from the positional cloning approach, we hypothesized on the basis of physiological data that the pancreas enriched KLF11 (also known as TIEG2) is a candidate gene on chr2p for susceptibility to T2D. KLF 11 encodes a TGFbeta-inducible transcription factor that functions as activator or repressor depending on cellular and promoter context. In Maturity-Onset Diabetes of the Young (MODY), a monogenic form of diabetes with an impaired beta-cell function, five of the six known genes involved are transcription factors that also play a role in the developing pancreas. Thus, the role of TGFbeta signalling in both pancreatic cell differentiation and growth suggest that an altered function of proteins within this pathway may contribute to diabetes. The TGFbeta induced KLF11 has recently elicited significant attention because it participates in morphogenetic pathways in exocrine pancreatic cells. It is also expressed in endocrine islet cells and glucose increases KLF11 expression in beta-cells, which suggests a role in glucose homeostasis. Indeed, our genetic and functional data on three missense KLF11 variants cosegregating R 85
Brief curriculum vitae and research work Bernadette Neve obtained a master degree in BioMedical Sciences at the university of Utrecht, the Netherlands, and, in 1998, a PhD at the Dept. of Biochemistry, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam. During her PhD she worked on the regulation of hepatic lipase expression at the post-transcriptional level in the research group of Prof. H. Jansen and Dr A.J.M. Verhoeven. Thereafter, she was attached to the research group of Prof. B. Staels, Dépt. d'Athérosclérose, U325 INSERM, Institut Pasteur de Lille, France. She received a grant from the Dutch "Catharine van Tussenbroek" foundation, and a European Community-awarded "Training and Mobility Research" grant to realise her work on nuclear receptors in cells of the vascular wall and their relation to atherosclerotic processes. In 2000 she joined the research group of Prof. P. Froguel, CNRS UMR8090, where she is currently working in the field of genetic susceptibility to diabetes.
Genes underlying susceptibility to Type 2 diabetes (T2D).
Prevalence of diabetes has grown to epidemic proportion, with 4% of the French population suffering from diabetes and is responsible for 3% to 6% of total healthcare expenditure in eight European countries (Diabetes Atlas 2000, International Diabetes Federation). The pathogenesis of T2D is complex and in with monogenic diabetes or associated with polygenic T2D, suggest a role for KLF11 in genetic predisposition to diabetes (Submitted manuscript) and prove the concept of the involvement of TGFbeta signalling mediators in diabetes. In close collaboration with other laboratories (e.g. Dr. R. Urrutia, Mayo Clinic Rochester, USA and Dr. D. Melloul, Hadassah University Hospital Jerusalem, Israel) I will study the mechanisms that underly the association of an altered KLF11 function with pathogenesis and severity of diabetes. The EFSD / Eli Lilly Research Fellowship in Diabetes and Metabolism will allow further development of a research program aimed at unravelling the role of the TGFbeta pathway and the SP1/XKLF transcription factor family in genetic susceptibility to diabetes. I would like to thank the EFSD and Eli Lilly for the honour of this award.
